Cost-effectiveness and fairness in health care: NICE appraisals

References

• Brazier , J. , Ratcliffe , J. , Salomon , J. A. and Tsuchiya , A. 2007 . Measuring and Valuing Health Benefits for Economic Evaluation , Oxford : Oxford University Press .
   Google Scholar
• Brouwer , W. B. F. , Culyer , A. J. , van Exel , N. J. A. and Rutten , F. H. 2008 . Welfarism vs. extrawelfarism . Journal of Health Economics , 27 : 325 – 338 .
   PubMed Web of Science ®Google Scholar
• Chao , D. 2008 . See www.nice.org.uk/nicemedia/live/11817/41519/41519.pdf
   Google Scholar
• Collier , J. 2010 . Drug pricing, NICE and the PPRS: government gets it right . British Medical Journal , 341 : 1136
   Web of Science ®Google Scholar
• Culyer , A. , McCabe , C. , Briggs , A. , Claxton , K. , Buxton , M. , Akehurst , R. , Sculpher , M. and Brazier , J. 2007 . Searching for a threshold, not setting one: the role of the National Institute for Health and Clinical Excellence . Journal of Health Service Research and Policy , 12 : 56 – 58 .
   PubMedGoogle Scholar
• Daniels , N. and Sabin , J. E. 2002 . Setting Limits Fairly: Can We Learn to Share Medical Resources? , Oxford : Oxford University Press .
   Google Scholar
• Department of Health . 2010 . A New Value-Based Approach to the Pricing of Branded Medicines , London : The Stationery Office .
   Google Scholar
• Devlin , N. and Parkin , D. 2004 . Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis . Health Economics , 13 : 437 – 452 .
   PubMed Web of Science ®Google Scholar
• Dolan , P. , Edlin , R. and Tsuchiya , A. 2009 . The Relative Societal Value of Health Gains to Different Beneficiaries , Sheffield : University of Sheffield .
   Google Scholar
• Drumond , M. F. , Wilson , D. A. , Kanavos , P. , Ubel , P. and Rovira , J. 2007 . Assessing the economic challenges posed by orphan drugs . International Journal of Technology Assessment in Health Care , 28 : 36 – 42 .
   Google Scholar
• R , Gold M. , E , Siegel J. , B , Russell L. and C , Weinstein M. 1996 . Cost-Effectiveness in Health and Medicine , Oxford : Oxford University Press .
   Google Scholar
• Harris , J. 1985 . The Value of Life , London : Routledge & Kegan Paul .
   Google Scholar
• Harris , J. 1991 . Unprincipled QALYs—a response to Cubbon . Journal of Medical Ethics , 17 : 195 – 188 .
   PubMed Web of Science ®Google Scholar
• Hayry , M. 2002 . “ Utilitarian approaches to justice in health care ” . In Medicine and Social Justice , Edited by: Rhodes , R. , Battin , M. P. and Silvers , A. 53 – 64 . London : Oxford University Press .
   Google Scholar
• Hurley , J. 2000 . “ An overview of the normative economics of the health care sector ” . In Handbook of Health Economics , Edited by: Culyer , A. J. and Newhouse , J. Amsterdam : Elsevier Science .
   Google Scholar
• NICE . 2008a . Social Value Judgements—Principles for the Development of NICE Guidance London
   Google Scholar
• NICE . 2008b . Guide to the Methods of Technology Appraisals London
   Google Scholar
• NICE . 2008c . Quality Adjusted Life Years (QALYs) and the Severity of Illness London
   Google Scholar
• NICE . 2008d . Bevacizumab, Sorafenib Tosylate, Sunitinib and Temsirolimus for Renal Cell Carcinoma: A Systematic Review and Economic Evaluation London
   Google Scholar
• NICE . 2008e . Overview—Bevacizumab, Sorafenib, Sunitinib and Temsirolimus for the Treatment of Advanced and/or Metastatic Renal Cell Carcinoma London
   Google Scholar
• NICE . 2009a . Appraising Life-Extending, End of Life Treatments London
   Google Scholar
• NICE . 2009b . Final Appraisal Determination: Sunitinib for the First-line Treatment of Advanced and/or Metastatic Renal Cell Carcinoma London
   Google Scholar
• Nord , E. 2001 . Severity of illness versus expected benefit in societal evaluation of healthcare interventions, expert review . Pharmoeconomics Outcomes Research , 1 : 85 – 92 .
   PubMedGoogle Scholar
• OFT . 2007 . The Pharmaceutical Price Regulation Scheme: An OFT Market Study London
   Google Scholar
• Rawls , J. 1972 . A Theory of Justice , Oxford : Oxford University Press .
   Google Scholar
• Rawlins , M. D. and Culyer , A. J. 2004 . National Institute for Clinical Excellence and its value judgements . British Medical Journal , 329 : 224 – 227 .
   PubMed Web of Science ®Google Scholar
• Sen , A. K. 1980 . “ Equality of what? ” . In The Tanner Lectures on Human Values , Edited by: McMurrin , S. Cambridge : Cambridge University Press .
   Google Scholar
• Shah , K. K. 2009 . Severity of illness and priorities setting in health care: a review of the literature . Health Policy , 93 : 77 – 84 .
   PubMed Web of Science ®Google Scholar
• Williams , A. 1993 . “ Cost-benefit analysis: applied welfare economics for general decision aid ” . In Efficiency in the Public Sector , Edited by: Williams , A. and Giardina , E. London : Edward Elgar .
   Google Scholar
• Williams , A. 2004 . What Could be Nicer than NICE? , London : Office for Health Economics .
   Google Scholar